Page 2,358«..1020..2,3572,3582,3592,360..2,3702,380..»

Discarded immune cells induce the relocation of stem cells

Posted: May 24, 2013 at 10:49 am

May 23, 2013 CNIC researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today in the journal Cell.

Neutrophils are leukocytes (white blood cells) that defend the body against attack from bacteria and other disease organisms. To perform their function, these cells release toxic substances when they come into contact with microorganisms. However, release of these substances in the wrong place by damaged neutrophils can result in severe injury to blood vessels and tissues. Evolution appears to have resolved this conflict by ensuring that neutrophils are renewed much more rapidly than most other cells in the body: approximately 1011 neutrophils are eliminated every day and an equivalent number of stem cells are released into the bloodstream. This in turn generates a second problem: what to do with all these cells that have to be eliminated.

Dr. Andrs Hidalgo and his team in the Department of Epidemiology, Atherosclerosis and Cardiovascular Imaging, led by Dr. Valentn Fuster, have discovered the function of these neutrophils expelled every day by the body.

Graduate student Mara Casanova Acebes (Universidad Autnoma de Madrid), found that when additional apoptotic neutrophils were injected into mice, there was an increase in the number of circulating hematopoietic stem cells, the cells that generate all blood cells.

Using a wide variety of experimental approaches, including imaging assays, pharmacological treatments and genetic analysis, the team showed that when neutrophils in the blood get old, they migrate to the bone marrow to be eliminated by specialized phagocytotic cells called macrophages. The act of phagocytosing the neutrophils alters these macrophages' genetic properties and functions, and these changes in turn alter the function of specialized cells whose job it is to retain hematopoietic stem cells in the bone marrow. "As a consequence, the stem cells are released into the blood," explains Mara Casanova, first author of the study.

According to Dr. Hidalgo, "Key questions that arise from our study relate to the role of the hematopoietic stems cells expelled from the bone marrow, and how the elimination of neutrophils might affect other important stem cell populations, for example those that produce tumors."

The research also reveals that the aging of neutrophils follows a day/night, or circadian, cycle, suggesting possible implications for disease processes -- for instance heart attack -- that occur more frequently at certain times of day.

"Our study shows that stem cells are affected by day/night cycles thanks to this cell recycling. It is possible that the malign stem cells that cause cancer use this mechanism to relocate, for example during metastasis," Hidalgo emphasizes.

But this finding could have more direct implications for cardiovascular health. According to the authors, the daily changes in the function of neutrophils could be responsible for the tendency of acute cardiovascular and inflammatory events, such as heart attack, sepsis or stroke, to occur at certain times of day.

Dr. Hidalgo concludes, "Given that this new discovery describes fundamental processes in the body that were unknown before, it will now be possible to interpret the alterations to certain physiological patterns that occur in many diseases."

The rest is here:
Discarded immune cells induce the relocation of stem cells

Posted in Stem Cells | Comments Off on Discarded immune cells induce the relocation of stem cells

Multimillion Dollar Carrots for Stem Cell Research in California

Posted: May 23, 2013 at 6:30 pm

Directors of the California stem cell
agency approved an $80 million business-friendly plan that will
dangle multimillion dollar carrots before biotech firms in an effort
to push therapies into the marketplace.

The upfront payment effort will allow
CIRM to take part in early stage clinical trials at no risk and could
generate a list of achievements that will be useful in creating
support for fresh funding after CIRM's money runs out in 2017.
The proposal is the first-ever from
CIRM that involves no upfront payments. Instead, recipients will have
to meet agreed-upon criteria to receive either grants or loans.
A CIRM staff document said,

“The major development milestone and
success criteria will be mutually agreed upon between CIRM and the
applicant at the beginning of the project(s) and at a minimum will
require completion of a clinical trial that shows some level of
biological activity/clinical efficacy and safety. The advantage to
CIRM of this...is that CIRM funds will only be applied to projects
that are successful.”

The proposal was wrapped into what the
agency calls its strategic partnership plan, which also has a more
conventional aspect, providing loans and grants in advance.
As part of the program, the CIRM board
also today approved a $6.4 million award to Sangamo BioSciences of
Richmond, Ca., to help develop a therapy for
beta-thalassemia. The firm will have to match the amount of the
award.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/uJidDBHhPdI/multimillion-dollar-carrots-for-stem.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Multimillion Dollar Carrots for Stem Cell Research in California

California Stem Cell Agency: 5 Percent Budget Increase for Coming Fiscal Year

Posted: May 23, 2013 at 4:27 pm

Directors of the California stem cell
agency today approved a $17.4 million operating budget for the fiscal
year beginning July 1, an increase of 5.1 percent over spending for
the current year.

As usual, the agency tries to portray
its budget as a decrease in spending. Directors were told that it
represented a 3 percent decline from the current year. However, the
comparison is not made to actual spending for this year. Instead, the
staff compares the 2013-14 budget to budget figures proposed last
May, which are now no more than time-worn ephemera.
Most of the budget goes for salaries
and benefits ($12.2 million ) with outside contracting running next
($2 million). (See here for details.) The budget projects 59 employees for next year
compared to 57 currently. CIRM staff said the number of employees is expected to remain about
the same until 2017 or so when its workload is projected to diminish.
The agency is expected to run out of
money for new grants in 2017, but it is working on a plan to develop
a combination of private and public funding to continue its work.
The spending plan reflects the cost of
overseeing about $1.8 billion in nearly 600 grants and loans plus
developing new research proposals that are likely to be funded in the
next few years. The operational budget is capped by law at 6 percent
of the amount of funds the agency distributes over its lifetime.  

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/GJSQ_B3ck_8/california-stem-cell-agency-5-percent.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on California Stem Cell Agency: 5 Percent Budget Increase for Coming Fiscal Year

$36 Million Recruitment: Names of Researchers Being Lured to California

Posted: May 23, 2013 at 3:02 pm

Here are the names of the researchers being recruited to California by the California stem cell agency with $36 million in awards. The sixth asked not to be revealed since he/she has yet to tell the current institution and are in
negotiations with their new institution

·      Hiromitsu
Nakauchi
of the University of Tokyo, who would be moving to Stanford
University
·      Barry
R. Stripp
of Duke moving to Cedars-Sinai Medical Center
·      Richard
Gregory
of Harvard and Children’s Hospital, Boston moving to UC
Santa Cruz
·      Eric
Ahrens
of Carnegie Mellon moving to UC San Diego

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/Kbc3TScH6ds/36-million-recruitment-names-of.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on $36 Million Recruitment: Names of Researchers Being Lured to California

Stem Cell Agency Approves $36 million to Recruit Six Scientists to California

Posted: May 23, 2013 at 2:34 pm

The California stem cell agency today
awarded $36 million to six scientists to lure them to the Golden
State, in what was the agency's largest-ever recruiting round.

The awards more than doubled the amount
of CIRM has spent on recruitment. Until today, the agency had awarded
only $23.2 million for four awards.
Today's awards ranged from $7.5 million
to $4.8 million. The agency did not immediately identify the recipients. However, testimony at the meeting indicated that two of the institutions involved were UC San Francisco and the Gladstone Institute (the $7.5 million award) and UC Santa Cruz (a $5.4 million award). (The agency later released the list, which can be found here. Here is a link to the CIRM press release.)

The differences in the size of the awards had to do with the overhead charges that are levied by the institutions at which the scientists would work, CIRM staff said. The "direct costs" of the research for each grant was $4.5 million.

Six applications were considered in the
latest round, including one that was scored at 75 that was rejected by grant reviewers. However, CIRM staff recommended that application, which involved UC San Francisco and Gladstone, be funded. (See here and here.)
Previous winners of the recruitment awards were Robert Wechsler-Reya, Sanford-Burnham; Dennis Steindler,
The Parkinson's Institute; Andrew McMahon, USC
, and Peter Coffey, UC
Santa Barbara.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/4jJo64qAjcY/stem-cell-agency-approves-36-million-to.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Stem Cell Agency Approves $36 million to Recruit Six Scientists to California

BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

Posted: May 23, 2013 at 1:50 pm

BOTHELL, Wash., May 23, 2013 /PRNewswire/ --BioLife Solutions, Inc. (BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced its participation at the Terrapinn World Stem Cells & Regenerative Medicine Congress 2013 this week in London.

(Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO)

Dr. Aby J. Mathew, BioLife's Senior Vice President and Chief Technology Officer, will make a presentation titled "Critical Stability and Biopreservation Considerations for Manufacturing, Storage and Clinical Delivery of Cell and Tissue Products," to the audience of executives and product development managers of commercial regenerative medicine companies. The presentation outlines the risk to clinical and commercial success of cell and tissue products due to stability limitations from the use of non-optimized storage, transport and cryopreservation freeze media. Comparative data illustrating the superior preservation efficacy of BioLife's HypoThermosol storage and shipping media, and CryoStor cryopreservation freeze media will be presented on relevant cell and tissue types.

Mike Rice, Chief Executive Officer, commented, "We continue to build traction in the high growth regenerative medicine market, and estimate that more than 65 percent of the presenting companies at this conference have adopted our best in class, clinical grade biopreservation media products. A key value-added service we provide, which directly translates into expanded product adoption, is the high quality consulting our team offers to prospective and current customers. Biopreservation outcomes such as cell and tissue shelf life, viability and recovery can greatly impact commercial potential. The combination of the efficacy and quality of our proprietary platform technology, along with our expert technical consulting services, is now recognized and highly valued in the development and commercialization of regenerative medicine products and therapies."

The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' recently published "Regenerative MedicineMarkets" report. BioLife's addressable portion of the market is the demand for reagents used to store, ship and freeze source material and manufactured doses of cell-based products and therapies.

For a list of upcoming events, please visit http://biolifesolutions.com/cell-therapy/category/events/.

About BioLife Solutions

BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The Company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce biopreservation-induced cell damage and death. BioLife's enabling technology provides academic and clinical researchers, and commercial companies significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit http://www.biolifesolutions.com, and follow BioLife on Twitter.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Read more from the original source:
BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

Posted in Regenerative Medicine | Comments Off on BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

FDA Has Seized Control of Your Stem Cells – Video

Posted: May 23, 2013 at 1:43 pm


FDA Has Seized Control of Your Stem Cells
This is the history of how FDA made your own adult stem cells subject to the same regulations as pharmaceuticals, without input from patients and their docto...

By: Mesen Chymal

Original post:
FDA Has Seized Control of Your Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on FDA Has Seized Control of Your Stem Cells – Video

The secret to cloning human embryos is caffeine – Video

Posted: May 23, 2013 at 1:43 pm


The secret to cloning human embryos is caffeine
The secret to cloning human embryos is caffeine A breakthrough in cloning embryonic stem cells could save lives.

By: TheCanalize

Read the original:
The secret to cloning human embryos is caffeine - Video

Posted in Stem Cell Videos | Comments Off on The secret to cloning human embryos is caffeine – Video

Maria’s Adult Stem Cells Anti Aging Testimonial – Video

Posted: May 23, 2013 at 1:43 pm


Maria #39;s Adult Stem Cells Anti Aging Testimonial
Adult Stem Cells Anti Aging have the highest percentage of growth factor complex to super-charge cell renewal. Maria is part of this scientific breakthrough ...

By: HumanCellsAntiAging

View original post here:
Maria's Adult Stem Cells Anti Aging Testimonial - Video

Posted in Stem Cell Videos | Comments Off on Maria’s Adult Stem Cells Anti Aging Testimonial – Video

History of Cancer Stem Cells – Video

Posted: May 23, 2013 at 1:43 pm


History of Cancer Stem Cells
Otolaryngology Grand Rounds - 5/9/2013 Speaker: Aggie Janisiewicz, MD, Chief Resident, Otolaryngology, Stanford Hospital Clinics.

By: Lane Library

See the original post here:
History of Cancer Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on History of Cancer Stem Cells – Video

Page 2,358«..1020..2,3572,3582,3592,360..2,3702,380..»